Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis.

Jin-Yue Li Li-Ying CuiXiao-Han SunDong-Chao ShenXun-Zhe YangQing LiuMing-Sheng Liu

Published in: Annals of clinical and translational neurology (2022)

The current study found altered levels of metabolic biomarkers in ALS patients, which may play a role in ALS pathogenesis. Adiponectin and visfatin represent potential biomarkers for prediction of disease progression in ALS.

Keyphrases

end stage renal disease
amyotrophic lateral sclerosis
newly diagnosed
ejection fraction
chronic kidney disease
metabolic syndrome
peritoneal dialysis
prognostic factors
insulin resistance
adipose tissue
patient reported outcomes
skeletal muscle